Identification and validation of UBE2B as a prognostic biomarker promoting the development of esophageal carcinomas
- DOI
- 10.3389/fimmu.2024.1295305
- Published
- 2024-02-28
- Container
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2024.1295305,
title = {Identification and validation of UBE2B as a prognostic biomarker promoting the development of esophageal carcinomas},
author = {Han Ding and Jia-Cheng Xu and Zhi-Guo Ding and Lin-Feng Wu and Yan-Bo Liu and Yi-Fei Zhang and Tian-Yin Chen and Yi-Qun Zhang and Ping-Hong Zhou},
year = {2024},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2024.1295305},
url = {https://doi.org/10.3389/fimmu.2024.1295305}
}RIS
TY - JOUR TI - Identification and validation of UBE2B as a prognostic biomarker promoting the development of esophageal carcinomas AU - Han Ding AU - Jia-Cheng Xu AU - Zhi-Guo Ding AU - Lin-Feng Wu AU - Yan-Bo Liu AU - Yi-Fei Zhang AU - Tian-Yin Chen AU - Yi-Qun Zhang AU - Ping-Hong Zhou PY - 2024 JO - Frontiers in Immunology DO - 10.3389/fimmu.2024.1295305 UR - https://doi.org/10.3389/fimmu.2024.1295305 ER -
APA
Ding, H., Xu, J., Ding, Z., Wu, L., Liu, Y., Zhang, Y., Chen, T., Zhang, Y., & Zhou, P. (2024). Identification and validation of UBE2B as a prognostic biomarker promoting the development of esophageal carcinomas. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2024.1295305
Source records
- crossref · retrieved 2026-11-10T12:14:15.268Z